Amgen, a drugmaker based in Thousand Oaks, Calif., will lay off 450 people — 2 percent of its workforce — with many separations occurring by May 26, according to a statement shared with Becker's. "We ...

In January, Amgen laid off about 300 employees as part of organizational changes, which "mainly" impacted the U.S.-based commercial team. "We made these changes to better manage against industry ...

(Reuters) -Amgen Inc said on Thursday it would cut 450 jobs, or less than 2% of its workforce, making it the company's second round of layoffs this year amid intensifying pressure on drug prices ...

Amgen is laying off more workers in Ventura County. The bio-pharmaceutical giant said March 16 that it will eliminate about 450 jobs, or less than 2% of its global workforce. That’s on top of 305 cuts ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our ...

On Monday the Supreme Court will hear oral arguments in Amgen v. Sanofi, a case with immense potential consequences for scientific innovation. If the high court upends settled patent law by ...

Amgen Inc. (NASDAQ: AMGN) is expected to report quarterly earnings at $4 per share on revenue of $6.26 billion, analysts say.

March 27 (Reuters) - Amgen Inc's (AMGN.O) battle with Sanofi (SASY.PA) and Regeneron (REGN.O) at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ...

The Supreme Court appeared to struggle Monday over Amgen Inc.'s arguments in a dispute with Sanofi S.A. that two canceled ...

The U.S. Supreme Court on Monday is set to hear a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a "blatant attempt" to ...

March 27 (Reuters) - Amgen Inc's battle with Sanofi and Regeneron at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ruling will reshape U.S. patent ...